(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 31.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 55.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Seer's revenue in 2025 is $15,309,000.On average, 1 Wall Street analysts forecast SEER's revenue for 2025 to be $1,032,559,559, with the lowest SEER revenue forecast at $1,032,559,559, and the highest SEER revenue forecast at $1,032,559,559. On average, 1 Wall Street analysts forecast SEER's revenue for 2026 to be $1,416,384,435, with the lowest SEER revenue forecast at $1,416,384,435, and the highest SEER revenue forecast at $1,416,384,435.
In 2027, SEER is forecast to generate $2,125,165,341 in revenue, with the lowest revenue forecast at $2,125,165,341 and the highest revenue forecast at $2,125,165,341.